Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : LVG00080Z
Storage : -80℃ Shipping : Frozen on dry ice
Titer: Size:
| Cat. No. | LVG00080Z |
| Description | Lentivirus particles containing luciferase reporter gene under the control of a minimal promoter and Activator Protein 1 (MAPK/JNK/AP1) response element. |
| Titer | Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc. |
| Size | Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc. |
| Storage | Store at -80℃. Avoid multiple freeze/thaw cycles. |
| Shipping | Frozen on dry ice |
| Summary | Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots. |
| Mycoplasma | Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination. |
| Purity | Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards. |
| Sterility | The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination. |
| Transducibility | Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities. |
| Proviral Identity Confirmation | All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert. |
The AP1 luciferase reporter lentiviral vector consists of lentiviral particles carrying a luciferase reporter gene, which is regulated by a minimal promoter and an activating protein 1 (AP1) response element. This lentiviral backbone efficiently and stably transduces both dividing and non-dividing cells, including primary cells and difficult-to-transfect cell types. The introduction of the AP1 response element allows researchers to sensitively monitor MAPK/JNK signaling pathway activity by quantitatively detecting luciferase expression. Due to genomic integration, this system enables long-term gene expression, while the minimal promoter design ensures low background noise and a high signal-to-noise ratio. Compared to transient transfection methods, this lentiviral approach yields more consistent and reproducible results in experiments. This reporter gene construct has been optimized for high sensitivity to AP1 transcription factor binding, making it an ideal tool for studying pathways converging on AP1 activation, such as stress responses, inflammatory signaling, and carcinogenesis.
This AP1 reporter lentivirus has broad applications in biomedical research and drug discovery. It is a powerful tool for studying MAPK/JNK pathway activation induced by various stimuli, including growth factors, cytokines, environmental stress, and pharmacological compounds. Researchers can use this system to screen for AP1 pathway inhibitors or activators in a high-throughput format, as luciferase readings are compatible with automated plate readers. The virus can be used to track AP1 activity long-term in cell culture models of inflammation, cancer progression, and neuronal signaling. In cancer research, it facilitates the study of AP1-mediated gene regulation during tumorigenesis and metastasis. The lentiviral vector format also allows for the creation of stable reporter cell lines, which can be used for repeated experiments over extended periods. Furthermore, this technology helps compare differences in AP1 signaling across different cell types and genetic backgrounds. When used in combination with other pathway-specific reporter genes, it can help researchers dissect the interactions between AP1 and other signaling networks.
Stimulation of transient receptor potential M3 (TRPM3) cation channels with pregnenolone sulfate induces an influx of Ca2+ ions into cells and results in an increase in intracellular Ca2+ concentration, which activates the activator protein 1 (AP-1) transcription factor. Here, the researchers show that expression of a constitutively active mutant of the Ca2+/calmodulin-dependent protein phosphatase calcineurin attenuates pregnenolone sulfate-induced AP-1 activation in TRPM3-expressing cells. Similarly, expression of the regulatory B subunit of calcineurin reduces AP-1 activity in cells following stimulation of TRPM3 channels. MAP kinase phosphatase 1 has been shown to attenuate TRPM3-mediated AP-1 activation. Here, the researchers show that pregnenolone sulfate-induced TRPM3 stimulation triggers phosphorylation and activation of the MAP kinase extracellular signal-regulated protein kinase (ERK1/2). Stimulation of ERK1/2 is essential for AP-1 activation in cells expressing stimulated TRPM3 channels. ERK1/2 is required for activation of the transcription factor c-Jun, a key component of the AP-1 transcription factor and regulates c-Fos promoter activity. Altogether, the data suggest that calcineurin and the protein kinases ERK1/2 and JNK1/2 are important regulators in the signaling cascade linking TRPM3 channel stimulation to increased AP-1-regulated transcription.
Calcineurin consists of two polypeptides, the catalytic calcineurin A subunit and the regulatory B subunit. Lentiviral gene transfer was used to express a constitutively active calcineurin A mutant, △CnA, which lacks the calmodulin binding site and the C-terminal autoinhibitory domain and does not require Ca2+ ions for activation. The domain structure of wild type and mutant calcineurin A is depicted in Fig. 1A. As a sensor to measure AP-1 activity, researchers used lentivirus containing the AP-1-responsive collagenase promoter/luciferase reporter gene. HEK293 cells containing a tetracyclineresponsive TRPM3 expression cassette were infected with a lentivirus containing the luciferase gene under the control of the collagenase promoter (Coll.luc). In addition, cells were either mock infected or infected with a lentivirus encoding the truncated calcineurin A mutant △CnA. Cells were treated with tetracycline to induce TRPM3 expression. Fig. 1B shows that expression of △CnA significantly reduced the activation of AP-1 in HEK293 cells expressing stimulated TRPM3 channels. Similar results were obtained after expressing △CnA-EGFP fusion protein in cells (Figure 1C, 1D). Visualization of EGFP expression showed that the fusion protein was mainly expressed in the cytosol (Figure 1E).
Figure 1. Expression of a constitutively active mutant of calcineurin A interrupts the signaling cascade connecting TRPM3 channels with the AP-1 transcription factor. (Lesch A, Rössler O G, Thiel G., 2017)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Creative Biogene has clearly put significant effort into ensuring product quality. The virus preparations had high titers and minimal background noise, which improved the overall clarity of my data.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.